Search Results - Simon Faissner
- Showing 1 - 20 results of 23
- Go to Next Page
-
1
-
2
-
3
-
4
Severe cerebellitis as a manifestation of infliximab-associated overlap of neurosarcoidosis and myelin oligodendrocyte glycoprotein antibody-associated disease – case report by Gregor Hütter, Maximilian Winkelhausen, Lars Tönges, Ralf Gold, Simon Faissner
Published in Frontiers in Immunology (2026-06-01)Get full text
Article -
5
-
6
-
7
-
8
-
9
1,25-OH2 vitamin D3 and AKT-inhibition increase glucocorticoid induced apoptosis in a model of T-cell acute lymphoblastic leukemia (ALL) by Maximilian Pistor, Lisa Schrewe, Steffen Haupeltshofer, Andrei Miclea, Simon Faissner, Andrew Chan, Robert Hoepner
Published in Leukemia Research Reports (2018-01-01)Get full text
Article -
10
-
11
Eomesodermin-expressing CD4+ Th cells and association with pregnancy in multiple sclerosis by Simon Faissner, Marielena Bongert, Paulina Trendelenburg, Sandra Thiel, Takashi Yamamura, Kerstin Hellwig, Ralf Gold
Published in Therapeutic Advances in Neurological Disorders (2024-02-01)Get full text
Article -
12
Disease-modifying therapies for relapsing/active secondary progressive multiple sclerosis – a review of population-specific evidence from randomized clinical trials by Antonios Bayas, Monika Christ, Simon Faissner, Juliane Klehmet, Refik Pul, Thomas Skripuletz, Sven G. Meuth
Published in Therapeutic Advances in Neurological Disorders (2023-01-01)Get full text
Article -
13
-
14
Corrigendum: Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series by Regina Berkovich, Jonathan Calkwood, Heidi Crayton, April Erwin, Simon Faissner, Ralf Gold, Joshua Katz, Mark Leekoff
Published in Frontiers in Immunology (2025-06-01)Get full text
Article -
15
The impact of the COVID-19 pandemic on hospitalizations and plasmapheresis therapy in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide analysis from Germ... by Daniel Richter, Simon Faissner, Dirk Bartig, Lars Tönges, Kerstin Hellwig, Ilya Ayzenberg, Christos Krogias, Ralf Gold
Published in Therapeutic Advances in Neurological Disorders (2021-07-01)Get full text
Article -
16
-
17
Neurological post-COVID syndrome is associated with substantial impairment of verbal short-term and working memory by Jeyanthan Charles James, Hannah Schulze, Nadine Siems, Christian Prehn, Daniel R. Quast, Nadine Trampe, Ralf Gold, Simon Faissner
Published in Scientific Reports (2025-01-01)Get full text
Article -
18
Retinal degeneration driven by brain-derived neurotrophic factor deficiency in microglia and T-lymphocytes by Sabrina Reinehr, Julia P. Zehge, Katharina Klöster, Maike Mueller, Hasan H. Hendek, Michael Sendtner, H. Burkhard Dick, Ralf Gold, Stephanie C. Joachim, Simon Faissner
Published in Scientific Reports (2025-10-01)Get full text
Article -
19
Correction: The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigm by Robert Hoffrogge, Anna Karachunskaya, Neele Heitmann, Steffen Haupeltshofer, Xiomara Pedreiturria, Katharina Klöster, Verian Bader, Konstanze F. Winklhofer, Michael Hamacher, Bert Klebl, Ralf Gold, Klaus Dinkel, Ingo Kleiter, Ingo Kleiter, Simon Faissner
Published in Frontiers in Immunology (2025-07-01)Get full text
Article -
20
The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigm by Robert Hoffrogge, Anna Karachunskaya, Neele Heitmann, Steffen Haupeltshofer, Xiomara Pedreiturria, Katharina Klöster, Verian Bader, Konstanze F. Winklhofer, Michael Hamacher, Bert Klebl, Ralf Gold, Klaus Dinkel, Ingo Kleiter, Ingo Kleiter, Simon Faissner
Published in Frontiers in Immunology (2025-04-01)Get full text
Article
